Ethical issues in cancer clinical trials

Area of Science:

• Clinical Research Methodology
• Medical Ethics

Background:

• Prospective randomized trials represent the gold standard in clinical research.
• Randomization is key to minimizing investigator and patient bias in study design.

Purpose of the Study:

• To highlight the ethical considerations of prospective randomized trials.
• To emphasize the role of the investigator in protecting human subjects.

Main Methods:

• Discussion of the ethical framework for randomized clinical trials.
• Analysis of factors influencing patient participation in investigational therapy.

Main Results:

• A well-designed trial is not inherently ethical; ethical conduct relies on the investigator.
• Patient motivation in advanced cancer trials includes hope, altruism, and trust in physician recommendations.

Conclusions:

• The responsible investigator is the primary safeguard for human subjects in clinical trials.
• Informed consent and ethical oversight are paramount for the integrity of randomized trials.